Residues | Conservation scores (g-value) | Molecular mechanisms disruption | |||||
---|---|---|---|---|---|---|---|
Functional impact | Pr-value | P-value | Structural impact | Pr-value | P-value | ||
(Probability) | (Probability) | ||||||
C52S | 0.960 | Altered Transmembrane protein; Altered Metal binding; Gain of Disulfide linkage at C49 | 0.29 0.28 0.12 | 3.7e-04 0.02 0.04 | |||
C114Y | 0.955 | Altered Metal binding; Altered Transmembrane protein; Gain of Sulfation at C114 | 0.56 0.12 0.02 | 2.9e-03 0.03 0.04 | |||
D115Y | 0.932 | Altered Metal binding; Altered Transmembrane protein; Gain of Sulfation at D115 | 0.56 0.09 0.01 | 2.9e-03 0.05 0.04 | |||
G128R | 0.869 | Altered Metal binding | 0.29 | 0.02 | |||
C131Y | 0.901 | Altered Metal binding; Gain of Pyrrolidone carboxylic acid at Q127 | 0.41 0.04 | 6.1e-03 0.05 | Gain of Strand | 0.26 | 0.04 |
V138M | 0.431 | - | - | - | |||
C150R | 0.970 | Altered Metal binding; Altered Transmembrane protein; Loss of Disulfide linkage at C150 | 0.55 0.11 0.22 | 3.0e-03 0.04 0.01 | Gain of Intrinsic disorder; Altered Disordered interface | 0.35 0.22 0.15 | 0.02 0.01 0.05 |
G159R | 0.741 | Altered Transmembrane Protein | 0.13 | 0.02 | Gain of Helix | 0.32 | 2.2e-0.3 |
G360S | 0.908 | Loss of Acetylation at K364; Altered DNA binding; Loss of Methylation at K364; Loss of Catalytic site at K359 | 0.24 0.20 0.15 0.14 | 0.02 0.02 0.02 0.03 | |||
L403P | 0.971 | Gain of Allosteric site at K400 | 0.23 | 0.02 | Gain of Intrinsic disorder | 0.35 | 0.02 |
L468P | 0.932 | Altered Metal binding; Gain of Allosteric site at H472; Altered Transmembrane protein; Altered DNA binding | 0.31 0.26 0.14 0.14 | 2.2e-03 9.1e-03 0.02 0.05 | Altered Ordered interface; | 0.28 | 0.04 |
D480Y | 0.946 | Altered Metal binding; Loss of Allosteric site at R479; Altered DNA binding; Altered Transmembrane protein; Loss of Catalytic site at D484; Gain of Sulfation at D480 | 0.77 0.31 0.23 0.15 0.14 0.01 | 5.4e-05 3.5e-03 0.01 0.01 0.03 0.04 | Altered Ordered interface; Altered Disordered interface; | 0.32 0.28 | 1.8e-03 0.04 |
Y521C | 0.945 | Altered Metal binding; Gain of Catalytic site at C516; Loss of Allosteric site at Y521; Altered Transmembrane protein; Gain of Disulfide linkage at C516; Loss of Sulfation at Y521; | 0.81 0.37 0.33 0.30 0.16 0.04 | 5.7e-04 2.8e-04 1.9e-03 1.3e-04 0.03 0.01 | Altered Ordered interface; Altered Disordered interface; Gain of Relative solvent accessibility | 0.44 0.29 0.26 | 5.7e-04 0.02 0.03 |
R597H | 0.771 | Altered DNA binding; Loss of Allosteric site at R597; Loss of Acetylation at K592; Loss of Amidation at P594 | 0.37 0.37 0.25 0.01 | 6.8e-04 9.2e-04 0.01 1.2e-03 | |||
F643L | 0.865 | Loss of Acetylation at K645 | 0.40 | 1.3e-03 | Altered Ordered interface; Gain of Helix | 0.29 0.27 | 0.03 0.04 |